# B cells and iBALT in TB immunity & pathogenesis

**Authors:** Taru S. Dutt, Robert Krause, David Hertz, Marcela Henao-Tamayo, Alasdair Leslie, Bianca Schneider

PMC · DOI: 10.3389/fimmu.2026.1743572 · Frontiers in Immunology · 2026-02-04

## TL;DR

This paper reviews how B cells and iBALT contribute to tuberculosis immunity, highlighting their role in immune responses and potential for vaccine development.

## Contribution

The paper synthesizes evidence on B cells and iBALT in TB, emphasizing their underappreciated roles and sex-based differences.

## Key findings

- B cells contribute to iBALT formation, which enhances localized immune responses in TB.
- Sex differences in iBALT formation may influence TB immunity and disease outcomes.
- B cells and iBALT have potential implications for TB vaccine development and immunotherapy.

## Abstract

B cells play a crucial role in immunity against various infectious diseases. However, their role in tuberculosis (TB) has been largely understudied. Emerging evidence suggests that B cells actively shape immune responses in TB. Beyond their classical functions, B cells contribute to the formation of inducible bronchus-associated lymphoid tissue (iBALT), a tertiary lymphoid structure (TLS) that enhances localized immune responses in the lungs. As iBALT is a site for B-T cell interactions and the generation of high-affinity antibodies, recent studies suggest that sex differences in iBALT formation influence TB immunity. This review synthesizes evidence from both TB and non-TB models to highlight the expanding role of B cells and iBALT, underscoring their potential implications for vaccine development and immunotherapy.

## Linked entities

- **Diseases:** tuberculosis (MONDO:0018076), TB (MONDO:0018076)

## Full-text entities

- **Genes:** Cxcl13 (C-X-C motif chemokine ligand 13) [NCBI Gene 55985] {aka 4631412M08Rik, ANGIE2, Angie, BCA-1, BLC, BLR1L}, CXCL13 (C-X-C motif chemokine ligand 13) [NCBI Gene 10563] {aka ANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, Lta (lymphotoxin A) [NCBI Gene 16992] {aka LT, LT-[a], LT-alpha, LT[a], LTalpha, Ltx}, CCL19 (C-C motif chemokine ligand 19) [NCBI Gene 6363] {aka CKb11, ELC, MIP-3b, MIP3B, SCYA19}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, Tnfsf13b (tumor necrosis factor (ligand) superfamily, member 13b) [NCBI Gene 24099] {aka BAFF, BLyS, D8Ertd387e, TALL-1, TALL1, THANK}, Il27 (interleukin 27) [NCBI Gene 246779] {aka IL-27, IL-27-A, IL-27p28, IL27-A, Il30, p28}, Tbx21 (T-box 21) [NCBI Gene 57765] {aka TBT1, Tbet, Tblym}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il21 (interleukin 21) [NCBI Gene 60505] {aka IL-21}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, LTBR (lymphotoxin beta receptor) [NCBI Gene 4055] {aka D12S370, LT-BETA-R, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP}, Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 22329] {aka CD106, Vcam-1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, Il22 (interleukin 22) [NCBI Gene 50929] {aka IL-22, IL-22a, ILTIFa, If2b1, Iltif}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Cxcr5 (C-X-C motif chemokine receptor 5) [NCBI Gene 12145] {aka Blr1, CXC-R5, CXCR-5, Gpcr6, MDR15}, Bcr (BCR activator of RhoGEF and GTPase) [NCBI Gene 110279] {aka 5133400C09Rik, mKIAA3017}, Fcr (Fc receptor) [NCBI Gene 109615], CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, CCL21 (C-C motif chemokine ligand 21) [NCBI Gene 6366] {aka 6Ckine, CKb9, ECL, SCYA21, SLC, TCA4}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, Ccr7 (C-C motif chemokine receptor 7) [NCBI Gene 12775] {aka CC-CKR-7, CCR-7, CD197, Cdw197, Cmkbr7, EBI1}, Ltbr (lymphotoxin B receptor) [NCBI Gene 17000] {aka LTbetaR, Ltar, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643] {aka BLR1, CD185, MDR15}, Ighv1-62 (immunoglobulin heavy variable 1-62) [NCBI Gene 668542] {aka IgG, IgM, IgVH, Igh}, Il20 (interleukin 20) [NCBI Gene 58181] {aka If2d, Zcyto10}, Icosl (icos ligand) [NCBI Gene 50723] {aka B7-H2, B7RP-1, B7h, GI50, GL50, GL50-B}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}
- **Diseases:** Respiratory syncytial virus (RSV) infection (MESH:D018357), cancer (MESH:D009369), Sjogren syndrome (MESH:D012859), Rheumatoid lung disease (MESH:D008171), CIA (MESH:D001169), eosinophilia (MESH:D004802), GVHD (MESH:D006086), Inflammatory (MESH:D007249), respiratory infections (MESH:D012141), granulomatous (MESH:D013968), influenza (MESH:D007251), SLE (MESH:D008180), autoimmune and inflammatory diseases (MESH:D001327), COPD (MESH:D029424), lung inflammation (MESH:D011014), infected (MESH:D007239), Pneumocystis infection (MESH:D016720), COVID-19 (MESH:D000086382), urinary tract infection (MESH:D014552), iBALT (MESH:D018442), LTBI (MESH:D055985), arthritis (MESH:D001168), pulmonary arterial hypertension (MESH:D000081029), viral disease (MESH:D014777), TSD (MESH:D013661), -infectious diseases (MESH:D003141), tetanus (MESH:D013746), chronic (MESH:D002908), TLS (MESH:D000072717), collagen (MESH:D003095), bacterial infections (MESH:D001424), measles (MESH:D008457), allergies (MESH:D004342), granulomas (MESH:D006099), Mtb (MESH:D014376)
- **Chemicals:** lipoarabinomannan (MESH:C050016), testosterone (MESH:D013739), LAM (-), lipid (MESH:D008055), LPS (MESH:D008070)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Bacillus sp. CG (species) [taxon 1196795], Rattus norvegicus (brown rat, species) [taxon 10116], Mycobacterium tuberculosis (species) [taxon 1773], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** /c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913489/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913489/full.md

## References

160 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913489/full.md

---
Source: https://tomesphere.com/paper/PMC12913489